Compounding Pharmacies in USA

Licensed pharmacies specializing in sterile peptide compounding (Section 503A or 503B). These facilities manufacture patient-specific or clinical-grade peptides under strict state and federal oversight. Compounding pharmacies operate under USP <797> and <795> standards for sterile and non-sterile preparations respectively, with 503B outsourcing facilities additionally subject to FDA cGMP inspection. FDA enforcement activity in 2024-2025 has intensively targeted unlicensed peptide compounding, particularly around GLP-1 products such as semaglutide and tirzepatide, with over 50 warning letters issued in September 2025 alone to compounders making unauthorized therapeutic claims. Showing 5 suppliers listed in USA.

Browse Compounding Pharmacies operating in USA serving pharmaceutical, biotech, and research customers. These suppliers offer USA-based manufacturing, distribution, and quality control for peptide products including Olympia Pharmacy, Empower Pharmacy, Hallandale Pharmacy and other vetted providers. Sourcing from USA-based compounding pharmacies provides advantages in regulatory compliance, shipping timelines, and supply chain transparency for buyers in this region.